Eprazinone

Eprazinone
Clinical data
Trade names	Eftapan, Isilung, Mucitux
AHFS/Drugs.com	International Drug Names
ATC code	R05CB04 (WHO) ;
Identifiers
	IUPAC name 3-[4-(2-ethoxy-2-phenyl-ethyl)piperazin-1-yl]-2-methyl-1-phenyl-propan-1-one;
CAS Number	10402-90-1 ;
PubChem CID	3245;
DrugBank	DB08990 ;
ChemSpider	3132 ;
UNII	883YNL63WU;
KEGG	D07902 ;
ChEBI	CHEBI:82716 ;
CompTox Dashboard (EPA)	DTXSID1048336 ;
ECHA InfoCard	100.030.782
Chemical and physical data
Formula	C24H32N2O2
Molar mass	380.532 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCOC(CN1CCN(CC1)CC(C)C(=O)C2=CC=CC=C2)C3=CC=CC=C3;
	InChI InChI=1S/C24H32N2O2/c1-3-28-23(21-10-6-4-7-11-21)19-26-16-14-25(15-17-26)18-20(2)24(27)22-12-8-5-9-13-22/h4-13,20,23H,3,14-19H2,1-2H3 ; Key:BSHWLCACYCVCJE-UHFFFAOYSA-N ;
	(what is this?) (verify)

Eprazinone (trade names Eftapan, Isilung, Mucitux) is a mucolytic and bronchospasm relieving drug.^[1] It has been marketed in many European countries, but not in the US or United Kingdom.^[2]

Indications

Indications include acute and chronic bronchitis, cough, rhinitis, and asthma.^[2]

Side effects

Adverse effects include headache, somnolence, vertigo, heartburn, and nausea.^[2]

References

[1]

[2]